Company · CIK 0001398733 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Aquestive Therapeutics, Inc. · AQST
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 16, 2:00 pm EDT | Daniel BarberPresident and CEO, Director | 25,000 | $4.82 | $120,487 | 652,317 | −3.69% | 10b5-1 |
| Sep 9, 2026 SForm 4 → | Sep 11, 11:07 am EDT | Sherry KorczynskiChief Commercial Officer | 8,750 | $5.22 | $45,675 | 235,689 | −3.58% | 10b5-1 |
| Sep 9, 2026 MForm 4 → | Sep 11, 11:07 am EDT | Sherry KorczynskiChief Commercial Officer | 8,750 | $2.65 | $23,188 | 244,439 | — | 10b5-1 |
| Sep 9, 2026 XForm 4 → | Sep 10, 9:21 am EDT | Peter E. BoydChief People Officer | 2,293 | $0.96 | $2,201 | 284,024 | — | |
| Sep 8, 2026 XForm 4 → | Sep 9, 5:10 pm EDT | Daniel BarberPresident and CEO, Director | 91,743 | $0.96 | $88,073 | 677,317 | — | |
| Sep 3, 2026 XForm 4 → | Sep 8, 4:06 pm EDT | Cassie JungChief Operating Officer | 4,587 | $0.96 | $4,404 | 206,833 | — | |
| Aug 17, 2026 SForm 4 → | Aug 18, 4:13 pm EDT | Daniel BarberPresident and CEO, Director | 25,000 | $4.29 | $107,168 | 585,574 | −4.09% | 10b5-1 |
| Aug 14, 2026 FForm 4 → | Aug 17, 5:33 pm EDT | Sherry KorczynskiChief Commercial Officer | 2,714 | $4.25 | $11,535 | 235,689 | — | |
| Jul 15, 2026 SForm 4 → | Jul 17, 1:15 pm EDT | Daniel BarberPresident and CEO | 25,000 | $4.01 | $100,192 | 610,574 | −3.93% | 10b5-1 |
| Jun 23, 2026 SForm 4 → | Jun 24, 11:11 am EDT | Julie KropDirector | 25,000 | $5.02 | $125,393 | 0 | −100% | 10b5-1 |
| Jun 23, 2026 MForm 4 → | Jun 24, 11:11 am EDT | Julie KropDirector | 25,000 | $0.7132 | $17,830 | 25,000 | — | 10b5-1 |
| Jun 15, 2026 SForm 4 → | Jun 16, 4:09 pm EDT | Daniel BarberPresident and CEO | 25,000 | $4.16 | $104,010 | 635,574 | −3.78% | 10b5-1 |
| Jun 8, 2026 FForm 4 → | Jun 9, 2:48 pm EDT | Sherry KorczynskiChief Commercial Officer | 2,714 | — | — | 238,403 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 MForm 4 → | Sep 11, 11:07 am EDT | Sherry KorczynskiChief Commercial Officer | 8,750 | — | — | 26,250 | — | 10b5-1 |
| Sep 9, 2026 XForm 4 → | Sep 10, 9:21 am EDT | Peter E. BoydChief People Officer | 2,293 | — | — | 0 | — | |
| Sep 8, 2026 XForm 4 → | Sep 9, 5:10 pm EDT | Daniel BarberPresident and CEO, Director | 91,743 | — | — | 0 | — | |
| Sep 3, 2026 XForm 4 → | Sep 8, 4:06 pm EDT | Cassie JungChief Operating Officer | 4,587 | — | — | 0 | — | |
| Jun 23, 2026 MForm 4 → | Jun 24, 11:11 am EDT | Julie KropDirector | 25,000 | — | — | 0 | — | 10b5-1 |
| Jun 10, 2026 AForm 4 → | Jun 12, 11:43 am EDT | Timothy E MorrisDirector | 50,500 | — | — | 50,500 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 11:43 am EDT | Julie KropDirector | 50,500 | — | — | 50,500 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 11:42 am EDT | Abigail L. JenkinsDirector | 50,500 | — | — | 50,500 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 11:42 am EDT | John CochranDirector | 50,500 | — | — | 50,500 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 11:42 am EDT | Gregory B BrownDirector | 50,500 | — | — | 50,500 | — | |
| Jun 10, 2026 AForm 4 → | Jun 12, 11:42 am EDT | Marco TagliettiDirector | 50,500 | — | — | 50,500 | — |